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Abstract
Introduction: Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids is a
brainstem disorder characterized by perivascular pathologic reaction with lymphocyte infiltration and leading to
diplopia, facial palsy, dysarthria, and gait ataxia. It was thought to be an autoimmune disorder without distinct
pathogenesis. Chronic hepatitis B virus infection has been proposed in correlation with autoimmune diseases,
including central nervous system demyelinating disease. Patients with chronic hepatitis B infection may develop the
syndrome of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids.
Case presentation: A 34-year-old Taiwanese man who had been a hepatitis B virus carrier for a decade presented
to our emergency room. He had influenza symptoms and progressive symptoms of left hemifacial numbness,
double vision, and an unsteady gait of 2 days’ duration. Chronic lymphocytic inflammation with pontine perivascular
enhancement responsive to steroids was diagnosed, with increased hepatitis B viral load at the same time. He had no
past history of similar neurologic deficits, and his liver function tests had been within normal limits before this episode.
After corticosteroid and entecavir treatments, his neurological deficits and neuroimaging anomalies improved and his
serum hepatitis B virus DNA viral load normalized.
Conclusions: Hepatitis B virus infection may induce central nervous system autoimmune reactions, including chronic
lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. In such cases, concomitant
administration of corticosteroids and antiviral agent was helpful. We suggest further investigations in patients with
regulatory T cell dysfunction, which may assist in clarifying a loss of immune tolerance in patients with such disorders.
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Introduction
Chronic lymphocytic inflammation with pontine perivas-
cular enhancement responsive to steroids (CLIPPERS) is
a disorder established since 2010 [1]. Its clinical features
include diplopia, facial palsy, dysarthria, and gait ataxia,
which result from a brainstem perivascular pathologic
reaction with lymphocytic infiltration. Brain magnetic
resonance imaging (MRI) reveals punctate and curvilin-
ear gadolinium enhancement in the pons, sometimes
with midbrain, cerebellum, spinal cord, or basal ganglia
involvement. CLIPPERS responds well to corticosteroid
treatment [1]. Even with good improvement in clinical
symptoms and resolution observed by neuroimaging
after treatment, recurrence or relapse may develop after
discontinuing or tapering corticosteroid therapy. The
distinct pathophysiology of CLIPPERS is still unknown.
Several studies suggested CLIPPERS as an autoimmune
disorder, but the hypothesis is still not well established,
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owing to a paucity of data [1, 2]. In this report, we de-
scribe a case of a patient with a clinical diagnosis of
CLIPPERS. He was a chronic hepatitis B virus (HBV)
carrier with elevated HBV DNA viral load. His presenta-
tion raised the possibility of HBV-associated immunity
and regulatory T cell (Treg) dysfunction as the cause of
the pathogenesis of CLIPPERS. To our knowledge, this
is the first case of CLIPPERS associated with the chronic
HBV infection reported to date.
Case presentation
A 34-year-old Taiwanese man was a known HBV carrier
for about 10 years. Headache, lightheadedness, neck
stiffness, and nausea and vomiting had developed 3
weeks before admission. One week after admission, left
hemifacial numbness, double vision, easily choking when
swallowing, frequent hiccup, and unsteady gait devel-
oped and progressed.
The patient had no cough, rhinorrhea, abdominal pain,
diarrhea, dysuria, urinary frequency, convulsive move-
ment, consciousness disturbance, or body weight loss.
He sought Chinese traditional medical therapy and acu-
puncture, but his neurologic symptoms persisted, espe-
cially the easily choking when swallowing. Therefore, he
presented to our emergency room.
Upon admission, the patient’s initial blood pressure
was 126/76 mmHg and his temperature was 37.3 °C.
His pulse rate was 68 beats/minute. A neurological
examination revealed impaired lateral gaze of both
eyes and mild deviation of the tongue to the left side.
Cerebellar dysarthria, wide-based gait ataxia, and bi-
lateral upper limb dysmetria were detected. The pa-
tient’s brain MRI showed swelling of the pons with
extensive hyperintensity on T2-weighted images that
extended to the midbrain and medulla. Punctate and
curvilinear enhancement was observed after contrast
dye injection (Fig. 1). A cerebrospinal fluid (CSF)
study disclosed pleocytosis (106 cells/μl) with lymphocyte
predominance (lymphocytes/neutrophils 97%/9%). Oligo-
clonal bands were detected (total protein 79.9 mg/dl, nor-
mal 15–45 mg/dl; immunoglobulin G (IgG) 9.72 mg/dl,
normal <3.4 mg/dl). Test results for herpes simplex virus
DNA and cryptococcal antigen in the CSF were both
negative. Serial autoimmune serum examination results,
including antinuclear antibodies, anti-DNA, cytoplasmic
antineutrophil cytoplasmic antibodies, perinuclear anti-
neutrophil cytoplasmic antibodies, rheumatoid factor,
complement C3 and C4 nephritic factors, IgM, IgG,
were all within normal limits, except for a slightly el-
evated IgA level (409 mg/dl, normal 70–400 mg/dl).
The patient’s anti-hepatitis B e (anti-HBe) antibody
test was positive. His total bilirubin was 0.56 mg/dl,
and his aspartate aminotransferase (AST) concentra-
tion was 24 U/L. An elevated HBV DNA viral load
(2250 IU/ml, normal <20 IU/mL) was detected.
Corticosteroid therapy was considered based on a ten-
tative diagnosis of CLIPPERS. Entecavir 1 mg/day was
given before a high-dose corticosteroid (1 g/day) after
consultation with a gastroenterologist. A maintenance
dose of 0.5 mg/day was started subsequently, followed
by prednisolone 70 mg/day. The patient’s bilateral lateral
gaze limitation, unsteady gait, dysarthria, and dysphagia
improved promptly. The patient was discharged 3 weeks
later with a good clinical response, and treatment was
continued with gradual tapering of prednisolone to 30
mg/day over the course of 6 months. Six months later,
nearly complete resolution of the brainstem lesion was
seen on MRI scans (Fig. 2). Normalization of the pa-
tient’s serum HBV DNA viral load (<20 IU/mL) and dis-
appearance of his neurologic deficit also were noted.
Discussion
Our patient had several clinical and typical radiologic
findings that met the diagnostic criteria for CLIPPERS,
although the tissue proof was not acquisitive. The diag-
nosis of CLIPPERS is generally based on clinical,
Fig. 1 a Fluid-attenuated inversion recovery image shows ill-defined hyperintensity involving the whole pons, which was associated with swelling
of the pons. b Postcontrast T1-weighted image shows multiple punctate and curvilinear enhancing lesions in the pons bilaterally
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radiological, and pathological findings and glucocortic-
oid response. Brain biopsy in critical areas of the brain-
stem has potential complications. A clinical diagnosis
based on typical image appearance is crucial [3], but cli-
nicians should still be aware of a constellation of various
presentations of CLIPPERS. Cautious exclusion of simi-
lar central nervous system (CNS) inflammation disorders
is mandatory.
The differential diagnosis should include Bickerstaff ’s
brainstem encephalitis, CNS vasculitis (primary angiitis
of the CNS), neuromyelitis optica, Sjögren’s syndrome
with CNS involvement, CNS lymphoma, and glioma
(especially when atypical clinical or MRI findings are
encountered), or when resistance to corticosteroid treat-
ment occurs [4]. Once the diagnosis is made, the treat-
ment should be started immediately to achieve an
optimal outcome, even if a biopsy is not performed for
pathologic proof.
Investigators proposed that this disorder is an auto-
immune process involving perivascular inflammatory
reaction, but the exact mechanism remains unknown.
Kastrup and colleagues described two cases of
CLIPPERS with elevated IgE level, and eosinophilic
granulocytes were absent in both cases [2]. IgE-related
neuroinflammation was considered [5]. Influenza vaccin-
ation–induced CLIPPERS has been reported as well [6].
Nevertheless, such hypersensitivity reactions may not
fully explain the pathogenesis of CLIPPERS. Further-
more, there is still no specific antineural surface antigen
antibody that can be recognized [7].
Our patient had been diagnosed as a chronic HBV car-
rier for more than 10 years. He had undergone regular
abdominal ultrasonography imaging and serum liver
function tests during that time. The liver echotexture
and serum biomarkers were all within normal limits. Be-
fore corticosteroid administration after his admission to
our hospital, elevated HBV DNA viral load (2250 IU/
ml) was detected. His serum HBe antigen was nega-
tive, his anti-HBe antibody was positive, and his AST
and alanine aminotransferase levels were within nor-
mal limits. With high-dose corticosteroid use, a flare-
up of his HBV infection was possible; thus, adding
antiviral therapy was a reasonable choice from both
therapeutic and prevention standpoints [8].
HBV infection has been proposed in correlation with
autoimmune diseases, such as multiple sclerosis (MS),
systemic lupus erythematosus, rheumatoid arthritis,
polymyalgia rheumatica, polymyositis, and autoimmune
liver disease. Several possible mechanisms have been
postulated: molecular mimicry, epitope spreading and
modification, viral or bacterial superantigens, release of
autoantigens during inflammation, or bystander activa-
tion [9–12]. For example, investigators who used an
animal model of MS experimental autoimmune enceph-
alomyelitis showed that rabbit T cells were reactive to
both injected HBV polymerase peptide and myelin basic
protein at the same amino acid, resulting in autoimmune
demyelinating encephalomyelitis [13]. In patients with
autoimmune liver disease caused by occult HBV infec-
tion, isolated serum HBV DNA was also detected in sig-
nificant proportions [14].
Xu and colleagues pointed that high serum HBV DNA
viral load has a positive correlation with circulating
CD4+CD25+Treg frequency in peripheral blood, sug-
gesting that an increase in Tregs correlates with im-
pairment in viral clearance [15], leading to persistence
of HBV infection [16]. Tregs are able to maintain
immunological homeostasis and suppress autoimmun-
ity against self-antigens [17]. Impaired Treg function
in peripheral blood caused by complex genetic defects
or environmental factors may play a role in HBV-
related, cell-mediated autoimmunity and may have
contributed to the increased HBV DNA viral load in
our patient.
Fig. 2 Images obtained 6 months after corticosteroid treatment. a Fluid-attenuated inversion recovery image. b Postcontrast T1-weighted image
showing nearly complete resolution of the patient’s pontine lesions
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We suggest adding anti-HBV therapy to steroid
therapy and monitoring of HBV viral activity in indi-
viduals diagnosed with CLIPPERS concomitant with
chronic HBV infection. Further surveys of the role of
Tregs in CLIPPERS may lead to a better understand-
ing of the pathogenesis of this disorder and help cli-
nicians to find a new strategy in developing more
effective therapy.
Conclusions
Increasing numbers of reports have recently indicated
that CLIPPERS is an emerging entity associated with an
autoimmunologic process involving the CNS. To the
best of our knowledge, we report the first case associated
with HBV infection. In our patient, the neurologic mani-
festation correlated well with HBV viral load. Long-term
corticosteroid use had been recommended for CLIP-
PERS because of the easily relapsing-remitting character
of the disease. When this disorder is accompanied by
chronic HBV infection, antiviral therapy is strongly
recommended. Thus, we assumed that dual use of an
antiviral agent and a steroid for suppression of virus-
associated autoimmune reaction is beneficial for treat-
ment. Further investigation of Tregs in CLIPPERS may
help to clarify the disease process.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Abbreviations
AST: aspartate aminotransferase; CLIPPERS: chronic lymphocytic inflammation
with pontine perivascular enhancement responsive to steroids; CNS: central
nervous system; CSF: cerebrospinal fluid; HBe: hepatitis B e; HBV: hepatitis B
virus; Ig: immunoglobulin; MRI: magnetic resonance imaging; MS: multiple
sclerosis; Treg: regulatory T cell.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CFW, DCC, and HHL made substantial contributions to the conception and
writing of the report. YFC and FCL added comments regarding radiology
and assisted in manuscript completion. All authors read and approved the
final manuscript.The authors extend special thanks to Professor HHL, who
provided instruction and made a major contribution to completing the
report.
Author details
1Department of Gerontology and Geriatrics, National Taiwan University
Hospital, Taipei, Taiwan. 2Department of Internal Medicine, National Taiwan
University Hospital, Taipei, Taiwan. 3Department of Medical Imaging, National
Taiwan University Hospital, Taipei, Taiwan. 4Department of Neurology,
National Taiwan University Hospital, No.1, Changde Street, Zhongzheng
District, Taipei City 10048, Taiwan.
Received: 11 May 2015 Accepted: 26 October 2015
References
1. Pittock SJ, Debruyne J, Krecke KN, Giannini C, van den Ameele J, De Herdt V,
et al. Chronic lymphocytic inflammation with pontine perivascular
enhancement responsive to steroids (CLIPPERS). Brain. 2010;133(9):2626–34.
2. Kastrup O, van de Nes J, Gasser T, Keyvani K. Three cases of CLIPPERS:
a serial clinical, laboratory and MRI follow-up study. J Neurol.
2011;258(12):2140–6.
3. Simon NG, Parratt JD, Barnett MH, Buckland ME, Gupta R, Hayes MW, et al.
Expanding the clinical, radiological and neuropathological phenotype of
chronic lymphocytic inflammation with pontine perivascular enhancement
responsive to steroids (CLIPPERS). J Neurol Neurosurg Psychiatry.
2012;83(1):15–22.
4. Limousin N, Praline J, Motica O, Cottier JP, Rousselot-Denis C, Mokhtari K,
et al. Brain biopsy is required in steroid-resistant patients with chronic
lymphocytic inflammation with pontine perivascular enhancement
responsive to steroids (CLIPPERS). J Neurooncol. 2012;107(1):223–4.
5. Tohge R, Nagao M, Yagishita A, Matsubara S. A case of chronic lymphocytic
inflammation with pontine perivascular enhancement responsive to steroids
(CLIPPERS) in East Asia. Intern Med. 2012;51(9):1115–9.
6. Hillesheim PB, Parker JR, Parker Jr JC, Escott E, Berger JR. Chronic
lymphocytic inflammation with pontine perivascular enhancement
responsive to steroids following influenza vaccination. Arch Pathol Lab Med.
2012;136(6):681–5.
7. Maddison P, Damian MS, Sewry C, McGorrian C, Winer JB, Odgerel Z, et al.
Clinical and myopathological characteristics of desminopathy caused by a
mutation in desmin tail domain. Eur Neurol. 2012;68(5):279–86.
8. Bárcena Marugán R, García GS. DNA-guided hepatitis B treatment,
viral load is essential, but not sufficient. World J Gastroenterol.
2009;15(4):423–30.
9. Matsui M, Kakigi R, Watanabe S, Kuroda Y. Recurrent demyelinating
transverse myelitis in a high titer HBs-antigen carrier. J Neurol Sci.
1996;139(2):235–7.
10. Ichiki Y, He XS, Shimoda S, Ishibashi H, Keeffe EB, Rossaro L, et al. T cell
immunity in hepatitis B and hepatitis C virus infection: implications for
autoimmunity. Autoimmun Rev. 2005;4(2):82–95.
11. Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune
disease. Clin Rev Allergy Immunol. 2008;34(1):85–102.
12. Chastain EM, Miller SD. Molecular mimicry as an inducing trigger for CNS
autoimmune demyelinating disease. Immunol Rev. 2012;245(1):227–38.
13. Fujinami RS, Oldstone MB. Amino acid homology between the
encephalitogenic site of myelin basic protein and virus: mechanism for
autoimmunity. Science. 1985;230(4729):1043–5.
14. Georgiadou SP, Zachou K, Liaskos C, Gabeta S, Rigopoulou EI, Dalekos GN.
Occult hepatitis B virus infection in patients with autoimmune liver diseases.
Liver Int. 2009;29(3):434–42.
15. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, et al. Circulating and liver
resident CD4+CD25+ regulatory T cells actively influence the antiviral
immune response and disease progression in patients with hepatitis B.
J Immunol. 2006;177(1):739–47.
16. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ,
Kusters JG, et al. Regulatory T cells contribute to the impaired immune
response in patients with chronic hepatitis B virus infection. Hepatology.
2005;41(4):771–8.
17. Costantino CM, Baecher-Allan CM, Hafler DA. Human regulatory T cells and
autoimmunity. Eur J Immunol. 2008;38(4):921–4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Weng et al. Journal of Medical Case Reports  (2015) 9:266 Page 4 of 4
